The mTOR is one of the well-studied down-stream targets of Akt and many studies have shown that the PI3K/Akt/mTOR pathway plays important roles in cancer, particularly cancer cell survival, growth and apoptosis resistance 29. This evidence concerns the gene AKT1 and cancer.